Related Experiment Video
Updated: Dec 2, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
The momentous role of N6-methyladenosine in lung cancer
Ruiyao Xu1, Gaozong Pang1, Qing Zhao1
1School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, China.
Abstract:
Lung cancer is the leading cause of cancer death worldwide. Although diagnostic methods and targeted drugs have been rapidly developed in recent years, the underlying molecular mechanisms in the pathogenesis of lung cancer remain enigmatic. The N6-methyladenosine (m6 A) modification is the most common modification of messenger RNA in eukaryotes and plays critical roles in many diseases, especially cancers. Ectopic m6 A modification is associated with human carcinogenesis, including lung cancer. The m6 A modification is mediated by methyltransferases (writers) and demethylases (erasers) and indirectly affects biological processes through the recruitment of specific reader proteins (readers). Many studies have shown that m6 A writers, erasers, and readers serve as specific and sensitive biomarkers for lung cancer diagnosis, prognosis, and therapy. This review summarizes recent studies on the biological functions of the m6 A modification in lung cancer and discusses the potential application of m6 A regulators in lung cancer diagnosis and therapeutics.
Insights
N6-methyladenosine (m6A) RNA modification is crucial in lung cancer. Regulators like m6A writers, erasers, and readers show potential as biomarkers for lung cancer diagnosis and treatment.
Area of Science:
- Molecular Biology
- Oncology
- Epigenetics
Background:
- Lung cancer is a leading global cause of cancer mortality.
- The molecular mechanisms driving lung cancer pathogenesis are not fully understood.
- N6-methyladenosine (m6A) modification, the most prevalent mRNA modification in eukaryotes, is implicated in various diseases, including cancer.
Purpose of the Study:
- To review the biological functions of m6A modification in lung cancer.
- To discuss the potential of m6A regulators as biomarkers for lung cancer diagnosis and therapeutics.
Main Methods:
- Literature review of recent studies on m6A modification in lung cancer.
- Analysis of the roles of m6A writers, erasers, and readers in lung cancer.
- Evaluation of m6A regulators as potential diagnostic and therapeutic targets.
Main Results:
- Aberrant m6A modification is linked to human carcinogenesis, specifically lung cancer.
- m6A modification is regulated by methyltransferases (writers) and demethylases (erasers).
- m6A modification influences biological processes via reader proteins.
Conclusions:
- m6A writers, erasers, and readers are emerging as sensitive and specific biomarkers for lung cancer.
- m6A regulators hold significant promise for improving lung cancer diagnosis, prognosis, and treatment strategies.
Related Concept Videos
RNA Stability
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
MicroRNAs
MicroRNAs

